Embya is a fertility-tracking app for IVF patients that uses AI to interpret hormone data and manage medication schedules on iOS.
The App DNA
What makes this app unique?
It replaces the friction of manual spreadsheets and clinic portals with a private, on-device companion that interprets complex clinical data into plain language.
For Individuals undergoing IVF treatment who require structured tracking for medications, hormones, and symptoms.
What does it look like?
Key features
Side-by-side analysis of two IVF cycles including follicle count and hormone peaks. Revenue Link: Premium-tier gate.
Real-time tracking of medication timing via Lock Screen integration. Revenue Link: Retention lever.
Reminder chains and dose tracking for IVF protocols. Revenue Link: Retention lever.
How much does it cost?
The 90-day Cycle Pass is a strategic lever to capture users who only require premium features during active treatment cycles.
Velocity
Steady developmentnew contentmonetizationUX improvementsShow more...
The app currently ships at a steady cadence, with one release recorded in the last 28 days. Development is focused on enhancing user utility through new home screen widgets and adjusting monetization models with the introduction of a single-cycle pass. The latest update also demonstrates a commitment to UX improvements by expanding free allowances and refining AI interaction flows. This release pattern suggests a stable, feature-driven development cycle.
Who built it?
Kurtulus Ahmet TEMEL
4 apps tracked · Health & Fitness
Packrist: Planejador Viagem
CalmExam: Exam Anxiety Coach
Plant Light Meter: Lux & PPFDUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for Embya: IVF Tracker & AI
How's the Health & Fitness market?
Embya enters the Health & Fitness category with a privacy-first, on-device processing value proposition. The absence of a public rating count suggests an early-stage market entry, requiring aggressive trust-building to compete with established clinic-provided tools.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Embya: IVF Tracker & AI
Where is it heading?
The fertility-tracking market is increasingly sensitive to data privacy, which positions Embya's on-device processing as a key competitive advantage. Continued feature expansion into cycle-specific tools will likely solidify its position as a primary companion for IVF patients over the next two quarters.
- The introduction of a 90-day Cycle Pass aligns monetization with the user's treatment timeline, which reduces friction for new users.
- The release cadence remains steady with one update in the last 28 days, indicating active development rather than maintenance mode.
The SWOT
- On-device data processing removes privacy barriers for sensitive fertility data
- Trigger Shot Live Activity provides high-utility, time-sensitive notifications
- Localized pricing could capture users in high-cost fertility markets
Next best moves
Implement a referral program for existing users because social proof is currently absent → increase install velocity
+ 1 more prioritized moveThe counter-intuitive read
The 90-day Cycle Pass is a superior retention…
Read the full takeBottom line
Embya's focus on AI-driven cycle comparison and privacy-first architecture provides a clear value proposition for IVF patients, but the lack of social proof remains a barrier to scaling; prioritizing user-generated testimonials will unlock the trust required to convert the free-tier funnel.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated